Bone metastasis: mechanisms, therapies, and biomarkers

The publication by American Physiological Society about pathophysiology of bone metastasis uncovers a realm of complexity. While various malignancies frequently find their way to the bones through metastasis, certain cancer types are more common towards establishing themselves in the skeletal structure—primarily breast and prostate cancers. The bone metastasis process unfolds as a multifaceted process: well before detectable metastases take shape, tumor cells find their place in the ordinary vascular and endosteal niches nestled within the bone marrow. These cells start growing only months later, commencing a phase of proliferation that gradually reshapes the activities of bone-resorbtion (osteoclasts) and bone-generation (osteoblasts). This gradual changes start a cascade of skeletal deterioration.
Diagnosis of bone metastasis could emerge during an asymptomatic stage, facilitated by advanced imaging modalities like computed tomography, positron emission tomography, and radionuclide bone scans. The radiographic characteristics of bone metastases encompasses a spectrum ranging from erosive (osteolytic) patterns to predominantly bone-forming (osteoblastic) formations. An asymmetry is commonly seen between the processes of bone creation and bone reabsorption throughout the progression of bone metastases.